Zebrafish neurofibromatosis type 1 genes have redundant functions in tumorigenesis and embryonic development

SUMMARY Neurofibromatosis type 1 (NF1) is a common, dominantly inherited genetic disorder that results from mutations in the neurofibromin 1 (NF1) gene. Affected individuals demonstrate abnormalities in neural-crest-derived tissues that include hyperpigmented skin lesions and benign peripheral nerve sheath tumors. NF1 patients also have a predisposition to malignancies including juvenile myelomonocytic leukemia (JMML), optic glioma, glioblastoma, schwannoma and malignant peripheral nerve sheath tumors (MPNSTs). In an effort to better define the molecular and cellular determinants of NF1 disease pathogenesis in vivo, we employed targeted mutagenesis strategies to generate zebrafish harboring stable germline mutations in nf1a and nf1b, orthologues of NF1. Animals homozygous for loss-of-function alleles of nf1a or nf1b alone are phenotypically normal and viable. Homozygous loss of both alleles in combination generates larval phenotypes that resemble aspects of the human disease and results in larval lethality between 7 and 10 days post fertilization. nf1-null larvae demonstrate significant central and peripheral nervous system defects. These include aberrant proliferation and differentiation of oligodendrocyte progenitor cells (OPCs), dysmorphic myelin sheaths and hyperplasia of Schwann cells. Loss of nf1 contributes to tumorigenesis as demonstrated by an accelerated onset and increased penetrance of high-grade gliomas and MPNSTs in adult nf1a+/−; nf1b−/−; p53e7/e7 animals. nf1-null larvae also demonstrate significant motor and learning defects. Importantly, we identify and quantitatively analyze a novel melanophore phenotype in nf1-null larvae, providing the first animal model of the pathognomonic pigmentation lesions of NF1. Together, these findings support a role for nf1a and nf1b as potent tumor suppressor genes that also function in the development of both central and peripheral glial cells as well as melanophores in zebrafish.

[1]  Antonio J Giraldez,et al.  Evaluation and application of modularly assembled zinc-finger nucleases in zebrafish , 2011, Development.

[2]  M. Granato,et al.  Chemical modulation of memory formation in larval zebrafish , 2011, Proceedings of the National Academy of Sciences.

[3]  A. Look,et al.  Oligodendrocyte progenitor cell numbers and migration are regulated by the zebrafish orthologs of the NF1 tumor suppressor gene. , 2010, Human molecular genetics.

[4]  Stephen L. Johnson,et al.  Differential contribution of direct-developing and stem cell-derived melanocytes to the zebrafish larval pigment pattern. , 2010, Developmental biology.

[5]  A. Look,et al.  Cardiac and vascular functions of the zebrafish orthologues of the type I neurofibromatosis gene NFI , 2009, Proceedings of the National Academy of Sciences.

[6]  E. Pasmant,et al.  Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1. , 2009, Human molecular genetics.

[7]  M. Mullins,et al.  Early zebrafish development: it's in the maternal genes. , 2009, Current opinion in genetics & development.

[8]  Stephen L. Johnson,et al.  Defects in ErbB-Dependent Establishment of Adult Melanocyte Stem Cells Reveal Independent Origins for Embryonic and Regeneration Melanocytes , 2009, PLoS genetics.

[9]  U. Strähle,et al.  gfap and nestin reporter lines reveal characteristics of neural progenitors in the adult zebrafish brain , 2009, Developmental dynamics : an official publication of the American Association of Anatomists.

[10]  Michael A Babcock,et al.  Neurofibromatosis Type 1 Revisited , 2009, Pediatrics.

[11]  D. Busam,et al.  An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.

[12]  Joshua M. Korn,et al.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.

[13]  D. Burns,et al.  Induction of abnormal proliferation by nonmyelinating schwann cells triggers neurofibroma formation. , 2008, Cancer cell.

[14]  D. Gutmann,et al.  Neurofibromatosis-1 regulates neuronal and glial cell differentiation from neuroglial progenitors in vivo by both cAMP- and Ras-dependent mechanisms. , 2007, Cell stem cell.

[15]  A. Tischler,et al.  Pheochromocytomas in Nf1 knockout mice express a neural progenitor gene expression profile , 2007, Neuroscience.

[16]  H. Burgess,et al.  Modulation of locomotor activity in larval zebrafish during light adaptation , 2007, Journal of Experimental Biology.

[17]  L. Parada,et al.  Tumor microenvironment and neurofibromatosis type I: connecting the GAPs , 2007, Oncogene.

[18]  Toni Cathomen,et al.  Structure-based redesign of the dimerization interface reduces the toxicity of zinc-finger nucleases , 2007, Nature Biotechnology.

[19]  Adam James Waite,et al.  An improved zinc-finger nuclease architecture for highly specific genome editing , 2007, Nature Biotechnology.

[20]  Michael Granato,et al.  Sensorimotor Gating in Larval Zebrafish , 2007, The Journal of Neuroscience.

[21]  R. Kelsh,et al.  A direct role for Sox10 in specification of neural crest-derived sensory neurons , 2006, Development.

[22]  W. Westbroek,et al.  Neurofibromatosis type 1 protein and amyloid precursor protein interact in normal human melanocytes and colocalize with melanosomes. , 2006, The Journal of investigative dermatology.

[23]  I. D'Angelo,et al.  A novel bipartite phospholipid‐binding module in the neurofibromatosis type 1 protein , 2006, EMBO reports.

[24]  D. Gutmann,et al.  Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation , 2005, Development.

[25]  H. Joensuu,et al.  NF1-Associated Gastrointestinal Stromal Tumors Have Unique Clinical, Phenotypic, and Genotypic Characteristics , 2005, The American journal of surgical pathology.

[26]  Dawen Zhao,et al.  Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma. , 2005, Cancer cell.

[27]  Hae-Chul Park,et al.  Oligodendrocyte Specification in Zebrafish Requires Notch-Regulated Cyclin-Dependent Kinase Inhibitor Function , 2005, The Journal of Neuroscience.

[28]  D. Gutmann,et al.  Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors. , 2005, Cancer research.

[29]  W. Talbot,et al.  erbb3 and erbb2 Are Essential for Schwann Cell Migration and Myelination in Zebrafish , 2005, Current Biology.

[30]  L. Zon,et al.  tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Catherine L Nutt,et al.  The Oligodendroglial Lineage Marker OLIG2 Is Universally Expressed in Diffuse Gliomas , 2004, Journal of neuropathology and experimental neurology.

[32]  A. Guha,et al.  Malignant peripheral nerve sheath tumors. , 2004, Neurosurgery clinics of North America.

[33]  Hae-Chul Park,et al.  Neural cell fate analysis in zebrafish using olig2 BAC transgenics. , 2003, Methods in cell science : an official journal of the Society for In Vitro Biology.

[34]  D. Gutmann,et al.  The Neurofibromatosis 1 Gene Product Neurofibromin Regulates Pituitary Adenylate Cyclase-Activating Polypeptide-Mediated Signaling in Astrocytes , 2003, The Journal of Neuroscience.

[35]  N. Ratner,et al.  Aberrant Growth and Differentiation of Oligodendrocyte Progenitors in Neurofibromatosis Type 1 Mutants , 2003, The Journal of Neuroscience.

[36]  J. Joly,et al.  I-SceI meganuclease mediates highly efficient transgenesis in fish , 2002, Mechanisms of Development.

[37]  Hae-Chul Park,et al.  olig2 is required for zebrafish primary motor neuron and oligodendrocyte development. , 2002, Developmental biology.

[38]  R. Plasterk,et al.  Target-Selected Inactivation of the Zebrafish rag1 Gene , 2002, Science.

[39]  Yinghua Zhu,et al.  Neurofibromin regulates G protein–stimulated adenylyl cyclase activity , 2002, Nature Neuroscience.

[40]  B. Thisse,et al.  A zebrafish nanos-related gene is essential for the development of primordial germ cells. , 2001, Genes & development.

[41]  M. Sheng,et al.  Bipartite Interaction between Neurofibromatosis Type I Protein (Neurofibromin) and Syndecan Transmembrane Heparan Sulfate Proteoglycans , 2001, The Journal of Neuroscience.

[42]  T. Jacks,et al.  NF1 Tumor Suppressor Gene Function Narrowing the GAP , 2001, Cell.

[43]  Y. Zhong,et al.  A neurofibromatosis-1-regulated pathway is required for learning in Drosophila , 2000, Nature.

[44]  M. Vidaud,et al.  Tandem duplication within the neurofibromatosis type 1 gene (NF1) and reciprocal t(15;16)(q26.3;q12.1) translocation in familial association of NF1 with intestinal neuronal dysplasia type B (IND B) , 2000, Journal of medical genetics.

[45]  Karlyne M. Reilly,et al.  Mouse models of tumor development in neurofibromatosis type 1. , 1999, Science.

[46]  S. Velasco-Miguel,et al.  Mouse tumor model for neurofibromatosis type 1. , 1999, Science.

[47]  D. Gutmann,et al.  Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation , 1999, Oncogene.

[48]  Y L Wang,et al.  Zebrafish hox clusters and vertebrate genome evolution. , 1998, Science.

[49]  B. Scheithauer,et al.  Perineurial malignant peripheral nerve sheath tumor (MPNST): a clinicopathologic, immunohistochemical, and ultrastructural study of seven cases. , 1998, The American journal of surgical pathology.

[50]  K. Shannon,et al.  Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1. , 1998, Blood.

[51]  M. Cayouette,et al.  Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders. , 1997, The New England journal of medicine.

[52]  D. Gutmann,et al.  Mutations in the GAP-related domain impair the ability of neurofibromin to associate with microtubules , 1997, Brain Research.

[53]  S. Hilsenbeck,et al.  Increased tumor proliferation and genomic instability without decreased apoptosis in MMTV-ras mice deficient in p53 , 1997, Molecular and cellular biology.

[54]  C. Moran,et al.  Liposarcoma of the anterior mediastinum and thymus. A clinicopathologic study of 28 cases. , 1995, The American journal of surgical pathology.

[55]  K. Omura,et al.  Prognostic factors of colorectal cancer: K‐ras mutation, overexpression of the p53 protein, and cell proliferative activity , 1994, Journal of surgical oncology.

[56]  Robert A. Weinberg,et al.  Tumour predisposition in mice heterozygous for a targeted mutation in Nf1 , 1994, Nature Genetics.

[57]  N. Copeland,et al.  Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. , 1994, Genes & development.

[58]  D. Easton,et al.  An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes. , 1993, American journal of human genetics.

[59]  P. O'Connell,et al.  Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus , 1990, Cell.

[60]  B. Brownstein,et al.  Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. , 1990, Science.

[61]  P. O'Connell,et al.  A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations , 1990, Cell.

[62]  B. Scheithauer,et al.  Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases , 1986, Cancer.

[63]  P. Gruss,et al.  Participation of p53 cellular tumour antigen in transformation of normal embryonic cells , 1984, Nature.

[64]  V. Rotter,et al.  Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation , 1984, Nature.

[65]  B. Thisse,et al.  High-resolution in situ hybridization to whole-mount zebrafish embryos , 2007, Nature Protocols.

[66]  M. Wegner,et al.  Oligodendroglial-specific Transcriptional Factor SOX10 is Ubiquitously Expressed in Human Gliomas , 2005, Journal of Neuro-Oncology.

[67]  K. Shannon,et al.  Mutations of the NF 1 Gene in Children With Juvenile Myelomonocytic Leukemia Without Clinical Evidence of Neurofibromatosis , Type 1 , 1998 .

[68]  M. Westerfield The zebrafish book : a guide for the laboratory use of zebrafish (Danio rerio) , 1995 .

[69]  A. Balmain,et al.  Transgenic approaches to the analysis of ras and p53 function in multistage carcinogenesis. , 1994, Cold Spring Harbor symposia on quantitative biology.

[70]  S. Vandenberg,et al.  Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases , 1993, Cancer.